About this item:

53 Views | 36 Downloads

Author Notes:

Brian C. Zanoni, MD, MPH, 2015 Upper Gate Drive NE, Atlanta, GA 30322, bzanoni@emory.edu, +1 (404) 727 - 0284

Author’s Contributions: Dr. Zanoni conceptualized and designed the study, performed the data analysis, drafted the initial manuscript, reviewed and revised the manuscript and approved the final manuscript as submitted. Kedibone Sithole performed the data collection, contributed to the drafting of the manuscript, critically reviewed the manuscript and approved the final manuscript as submitted. Nzwakie Mosery performed the data collection, contributed to the drafting of the manuscript, critically reviewed the manuscript and approved the final manuscript as submitted. Michael Wilson assisted with the conceptualization and design of the study, contributed to the data collection, and critically reviewed the manuscript, and approved the final manuscript as submitted. Shannon Bosman contributed to the data collection, and critically reviewed the manuscript, and approved the final manuscript as submitted. Cecilia Milford assisted with the conceptualization and design of the study, contributed to the analysis plan, reviewed and revised the manuscript, and approved the final manuscript as submitted. Jennifer Smit assisted with the conceptualization and design of the study, contributed to the analysis plan, reviewed and revised the manuscript, and approved the final manuscript as submitted.

The authors have no conflicts of interest relevant to this article to disclose.

Subjects:

Research Funding:

This work was supported via: Center for AIDS Research at Emory University (P30AI050409)

High risk injection drug use and uptake of HIV prevention and treatment services among people who inject drugs in KwaZulu-Natal, South Africa.

Tools:

Journal Title:

medRxiv

Publisher:

Type of Work:

Article | Preprint: Prior to Peer Review

Abstract:

The use of injection drugs in South Africa is increasing. HIV prevention, treatment and addiction services for people who inject drugs (PWID) in South Africa are not well documented. We conducted a mixed-methods study to understand current drug use practices and access to HIV prevention and treatment services for PWID in KwaZulu-Natal, South Africa. We used respondent-driven sampling to recruit 45 people who reported injecting opiates within the past 6 months from Durban, KwaZulu-Natal, South Africa. We found high rates of practices that increase HIV/viral hepatitis risk including the use of shared needles (43%) and direct blood injections (bluetoothing) (18%). Despite 35% of participants living with HIV, only 40% accessed antiretroviral therapy within the past year, and one accessed PrEP. None of the participants reported ever testing for Hepatitis C.

Copyright information:

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote